# Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development

> **NCT02949726** · PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 80 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** Indocyanine Green (ICG)
- **DEVICE:** Near-infrared Fluorescence Lymphatic Imaging (NIRFLI)

## Key facts

- **NCT ID:** NCT02949726
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-12-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949726, "Lymphatic and Systemic Immunity Changes in Post-radiation Lymphedema Development". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02949726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*